TQF3250
/ Sino Biopharm
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
December 04, 2025
…Sino Biopharmaceutical…announces that the clinical trial application for its self-developed innovative drug, TQF3250 capsules…has been approved by the China National Medical Products Administration (NMPA) and the United States Food and Drug Administration (FDA), intended for weight loss
(HKEXnews)
IND • New trial • Obesity
1 to 1
Of
1
Go to page
1